Related references
Note: Only part of the references are listed.Expression of Novel CD44st and MMP2 in NSCLC Tissues and Their Clinical Significance
Lei Zhang et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies
Dejan Juric et al.
CLINICAL CANCER RESEARCH (2017)
Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective
Luca Carlino et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
Timothy P. Heffron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
Cristian Massacesi et al.
ONCOTARGETS AND THERAPY (2016)
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Catherine A. Evans et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J. A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Phase I dose- escalation study of buparlisib ( BKM120), an oral pan- class I PI3K inhibitor, in Japanese patients with advanced solid tumors
Yuichi Ando et al.
CANCER SCIENCE (2014)
GSK-3-at the crossroads of cell death and survival
Ulrich Maurer et al.
JOURNAL OF CELL SCIENCE (2014)
Idelalisib - A PI3Kδ Inhibitor for B-Cell Cancers
David A. Fruman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dietary regulation of PI3K/AKT/GSK-3 beta pathway in Alzheimer's disease
Yasuko Kitagishi et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Assessment of Mutagenic Effect of G. acerosa and S. wightii in S. typhimurium (TA 98, TA 100, and TA 1538 strains) and Evaluation of Their Cytotoxic and Genotoxic Effect in Human Mononuclear Cells: A Non-Clinical Study
Arif Nisha Syad et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Molecular Profiling in Non-Small Cell Lung Cancer
Kirtee Raparia et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Differential growth inhibition of cancer cell lines and antioxidant activity of extracts of red, brown, and green marine algae
Kavitha Murugan et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2013)
Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression
Sun Young Park et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis
Tetsuya Kurosu et al.
PLOS ONE (2013)
Caspase Functions in Cell Death and Disease
David R. McIlwain et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Assessment of Anticholinesterase Activity of Gelidiella acerosa: Implications for Its Therapeutic Potential against Alzheimer's Disease
Arif Nisha Syad et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies
John G. Foster et al.
PHARMACOLOGICAL REVIEWS (2012)
Clonogenic Assay: Adherent Cells
Haloom Rafehi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
Valsamo K. Anagnostou et al.
BMC CANCER (2010)
The Role of the Akt/mTOR Pathway in Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CLINICAL CANCER RESEARCH (2010)
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
I. K. Demedts et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling
L. Li et al.
ONCOGENE (2010)
Targeting phosphoinositide 3-kinase - Moving towards therapy
Romina Marone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Bioprotective properties of seaweeds: In vitro evaluation of antioxidant activity and antimicrobial activity against food borne bacteria in relation to polyphenolic content
Kasi Pandima Devi et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway
Byeong Hyeok Choi et al.
CANCER LETTERS (2008)
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
Violeta Serra et al.
CANCER RESEARCH (2008)
Catch of the day: zebrafish as a human cancer model
K. Stoletov et al.
ONCOGENE (2008)
Agars of Gelidiella acerosa of west and southeast coasts of India
Kamalesh Prasad et al.
BIORESOURCE TECHNOLOGY (2007)
Chemically targeting the PI3K family
Z. A. Knight et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Antioxidant properties of Cortex Fraxini and its simple coumarins
Chi-Rei Wu et al.
FOOD CHEMISTRY (2007)
Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
Anthony J. Alberg et al.
CHEST (2007)
Relationship between matrix metalloproteinase 2 and lung cancer progression
Chun-Bao Guo et al.
MOLECULAR DIAGNOSIS & THERAPY (2007)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
SJ Kim et al.
LUNG CANCER (2005)
Plants as a source of anti-cancer agents
GM Cragg et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Drugs from the deep: marine natural products as drug candidates
B Haefner
DRUG DISCOVERY TODAY (2003)
Matrix metalloproteinases in lung diseases
H Ohbayashi
CURRENT PROTEIN & PEPTIDE SCIENCE (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Serum levels of matrix metalloproteinase 2 in patients with breast cancer
SM Sheen-Chen et al.
CANCER LETTERS (2001)
Share Paper
